Print PDF
Axinn Granted Summary Judgment in Delaware Federal Court
June 24, 2014

A Delaware federal judge on June 24 granted summary judgment to Axinn client Alvogen in a lawsuit brought by Novartis AG over a generic version of the Exelon dementia treatment patch.  After the close of fact discovery, Novartis granted a covenant not to sue to Alvogen.  Axinn partner Chad Landmon and associate Thomas Hedemann represented Alvogen.  

Click here to read about the judgment in Law360’s article.  

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.